Cross-reactive influenza virus-specific CD8+ T cells contribute to lymphoproliferation in Epstein-Barr virus-associated infectious mononucleosis.

The marked proliferation of activated CD8+ T cells is pathognomonic of EBV-associated infectious mononucleosis (IM), common in young adults. Since the diversity and size of the memory CD8+ T cell population increase with age, we questioned whether IM was mediated by the reactivation of memory CD8+ T cells specific to previously encountered pathogens but cross-reactive with EBV. Of 8 HLA-A2+ IM patients, 5 had activated T cells specific to another common virus, as evidenced by a significantly higher number of peripheral blood influenza A virus M1(58-66)-specific T cells compared with healthy immune donors. Two patients with an augmented M1 response had tetramer-defined cross-reactive cells recognizing influenza M1 and EBV-BMLF1(280-288), which accounted for up to one-third of their BMLF1-specific population and likely contributed to a skewed M1-specific T cell receptor repertoire. These epitopes, with only 33% sequence similarity, mediated differential effects on the function of the cross-reactive T cells, which may contribute to alterations in disease outcome. EBV could potentially encode an extensive pool of T cell epitopes that activate other cross-reactive memory T cells. Our results support the concept that cross-reactive memory CD8+ T cells activated by EBV contribute to the characteristic lymphoproliferation of IM.

[1]  A. Bertoletti,et al.  Heterologous T cell immunity in severe hepatitis C virus infection , 2005, The Journal of experimental medicine.

[2]  R. Welsh,et al.  Private specificities of CD8 T cell responses control patterns of heterologous immunity , 2005, The Journal of experimental medicine.

[3]  J. Falloon,et al.  Vaccination in Humans Generates Broad T Cell Cytokine Responses1 , 2004, The Journal of Immunology.

[4]  L. Young,et al.  Epstein–Barr virus: 40 years on , 2004, Nature Reviews Cancer.

[5]  L. Meyer,et al.  CD8+ T Cells Specific for EBV, Cytomegalovirus, and Influenza Virus Are Activated during Primary HIV Infection1 , 2004, The Journal of Immunology.

[6]  Jun Liu,et al.  Cutting Edge: Pulmonary Immunopathology Mediated by Antigen-Specific Expression of TNF-α by Antiviral CD8+ T Cells1 , 2004, The Journal of Immunology.

[7]  A. Swerdlow,et al.  Analysis of immune activation and clinical events in acute infectious mononucleosis. , 2004, The Journal of infectious diseases.

[8]  S. Migueles,et al.  The Functional Profile of Primary Human Antiviral CD8+ T Cell Effector Activity Is Dictated by Cognate Peptide Concentration , 2004, The Journal of Immunology.

[9]  R. Welsh,et al.  Immunological Memory to Viral Infections1 , 2004 .

[10]  K. Kawa,et al.  Selective Induction of Th2-Attracting Chemokines CCL17 and CCL22 in Human B Cells by Latent Membrane Protein 1 of Epstein-Barr Virus , 2004, Journal of Virology.

[11]  Tao Dong,et al.  Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever , 2003, Nature Medicine.

[12]  H. Pilch,et al.  Human Papillomavirus Type 16 E7 Peptide-Directed CD8+ T Cells from Patients with Cervical Cancer Are Cross-Reactive with the Coronavirus NS2 Protein , 2003, Journal of Virology.

[13]  E. Naumova,et al.  A Fractal Clonotype Distribution in the CD8+ Memory T Cell Repertoire Could Optimize Potential for Immune Responses1 , 2003, The Journal of Immunology.

[14]  M. Bonneville,et al.  Dominant TCR Vα  usage by virus and tumor‐reactive T cells with wide affinity ranges for their specific antigens , 2002, European journal of immunology.

[15]  R. Welsh,et al.  T cell immunodominance and maintenance of memory regulated by unexpectedly cross-reactive pathogens , 2002, Nature Immunology.

[16]  Raymond M. Welsh,et al.  No one is naive: the significance of heterologous T-cell immunity , 2002, Nature Reviews Immunology.

[17]  S. L. Silins,et al.  Asymptomatic primary Epstein-Barr virus infection occurs in the absence of blood T-cell repertoire perturbations despite high levels of systemic viral load. , 2001, Blood.

[18]  J. Bennink,et al.  Cross-Reactivity between Hepatitis C Virus and Influenza A Virus Determinant-Specific Cytotoxic T Cells , 2001, Journal of Virology.

[19]  L. Borysiewicz,et al.  Functional differences between influenza A-specific cytotoxic T lymphocyte clones expressing dominant and subdominant TCR. , 2001, International immunology.

[20]  M. Zambon,et al.  Influenza A antigen exposure selects dominant Vbeta17+ TCR in human CD8+ cytotoxic T cell responses. , 2001, International immunology.

[21]  A. Fraire,et al.  Memory CD8+ T cells in heterologous antiviral immunity and immunopathology in the lung , 2001, Nature Immunology.

[22]  M. Catalina,et al.  Differential Evolution and Stability of Epitope-Specific CD8+ T Cell Responses in EBV Infection1 , 2001, The Journal of Immunology.

[23]  T. Rea,et al.  Prospective study of the natural history of infectious mononucleosis caused by Epstein-Barr virus. , 2001, The Journal of the American Board of Family Practice.

[24]  B. Golding,et al.  Human Peripheral Blood T Cells, Monocytes, and Macrophages Secrete Macrophage Inflammatory Proteins 1α and 1β following Stimulation with Heat-Inactivated Brucella abortus , 2001, Infection and Immunity.

[25]  A. McMichael,et al.  CD8(+) T-cell selection, function, and death in the primary immune response in vivo. , 2000, The Journal of clinical investigation.

[26]  J. Bell,et al.  Functional Heterogeneity and High Frequencies of Cytomegalovirus-Specific CD8+ T Lymphocytes in Healthy Seropositive Donors , 2000, Journal of Virology.

[27]  Douglas D. Richman,et al.  HIV-Specific Cd8+ T Cells Produce Antiviral Cytokines but Are Impaired in Cytolytic Function , 2000, The Journal of experimental medicine.

[28]  A. Rothman,et al.  Immunopathogenesis of Dengue hemorrhagic fever. , 1999, Virology.

[29]  S. L. Silins,et al.  Crossreactive recognition of viral, self, and bacterial peptide ligands by human class I-restricted cytotoxic T lymphocyte clonotypes: implications for molecular mimicry in autoimmune disease. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[30]  P. Auwaerter Infectious mononucleosis in middle age. , 1999, JAMA.

[31]  S. Varga,et al.  Protective Heterologous Antiviral Immunity and Enhanced Immunopathogenesis Mediated by Memory T Cell Populations , 1998, The Journal of experimental medicine.

[32]  J. Altman,et al.  Individual variations in the murine T cell response to a specific peptide reflect variability in naive repertoires. , 1998, Immunity.

[33]  A. Kumar,et al.  Immediate Early and Early Lytic Cycle Proteins Are Frequent Targets of the Epstein-Barr Virus–induced Cytotoxic T Cell Response , 1997, The Journal of experimental medicine.

[34]  R. Germain,et al.  Variant TCR ligands: new insights into the molecular basis of antigen-dependent signal transduction and T-cell activation. , 1996, Seminars in immunology.

[35]  A. Lanzavecchia,et al.  Different responses are elicited in cytotoxic T lymphocytes by different levels of T cell receptor occupancy , 1996, The Journal of experimental medicine.

[36]  Tak W. Mak,et al.  Human T-cell receptor variable gene segment families , 1995, Immunogenetics.

[37]  J. Gorski,et al.  Molecular analysis of T cell repertoires. Spectratypes generated by multiplex polymerase chain reaction and evaluated by radioactivity or fluorescence. , 1995, Human immunology.

[38]  J. Bell,et al.  Human HLA-A0201-restricted cytotoxic T lymphocyte recognition of influenza A is dominated by T cells bearing the V beta 17 gene segment , 1995, The Journal of experimental medicine.

[39]  J. Cabaniols,et al.  Public and private V beta T cell receptor repertoires against hen egg white lysozyme (HEL) in nontransgenic versus HEL transgenic mice , 1994, The Journal of experimental medicine.

[40]  R. Welsh,et al.  Cross-reactivities in memory cytotoxic T lymphocyte recognition of heterologous viruses , 1994, The Journal of experimental medicine.

[41]  J. Burrows,et al.  An alloresponse in humans is dominated by cytotoxic T lymphocytes (CTL) cross-reactive with a single Epstein-Barr virus CTL epitope: implications for graft-versus-host disease , 1994, The Journal of experimental medicine.

[42]  H. Stein,et al.  Patterns of cytokine gene expression in infectious mononucleosis. , 1994, Blood.

[43]  J. Bell,et al.  Extensive conservation of alpha and beta chains of the human T-cell antigen receptor recognizing HLA-A2 and influenza A matrix peptide. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[44]  U. Nater,et al.  Epstein-Barr virus. , 1991, The Journal of family practice.

[45]  P. Axelrod,et al.  Infectious mononucleosis in older adults. , 1990, American family physician.

[46]  R. Maziarz,et al.  Characterization of the T cell-mediated cellular cytotoxicity during acute infectious mononucleosis. , 1989, Journal of immunology.

[47]  A. Lesk,et al.  The outline structure of the T‐cell alpha beta receptor. , 1988, The EMBO journal.

[48]  A. McMichael,et al.  Cytotoxic T lymphocytes recognize a fragment of influenza virus matrix protein in association with HLA-A2 , 1987, Nature.

[49]  R. Hopkins,et al.  Spontaneous release of a factor with properties of T cell growth factor from a continuous line of primate tumor T cells. , 1981, Journal of immunology.

[50]  S. Talbot,et al.  Infectious mononucleosis. , 1971, British medical journal.

[51]  R. Welsh,et al.  Immunological memory to viral infections. , 2004, Annual review of immunology.

[52]  M. Callan The evolution of antigen-specific CD8+ T cell responses after natural primary infection of humans with Epstein-Barr virus. , 2003, Viral immunology.

[53]  T. Wölfel,et al.  The use of HLA-A*0201-transfected K562 as standard antigen-presenting cells for CD8(+) T lymphocytes in IFN-gamma ELISPOT assays. , 2002, Journal of immunological methods.

[54]  D. Torre,et al.  Acyclovir for treatment of infectious mononucleosis: a meta-analysis. , 1999, Scandinavian journal of infectious diseases.

[55]  P. Allen,et al.  Altered peptide ligand-induced partial T cell activation: molecular mechanisms and role in T cell biology. , 1996, Annual review of immunology.

[56]  P. Vassalli,et al.  The pathophysiology of tumor necrosis factors. , 1992, Annual review of immunology.

[57]  A. Rickinson,et al.  Multiple HLA class I‐dependent cytotoxicities constitute the “non‐HLA‐restricted” response in infectious mononucleosis , 1987, European journal of immunology.

[58]  J. Giesecke,et al.  Acyclovir treatment in infectious mononucleosis: A clinical and virological study , 1987, Infection.